43 / 45
43
REFERÊNCIAS
1.
Hughes RA, Cornblath DR. Guillain-Barré
syndrome. Lancet 2005;366:1653-66.
2.
Atkinson SB, Carr RL, Maybee P, Haynes D. The
challenges of managing and treating Guillain-Barré
syndrome during the acute phase. Dimens Crit
Care Nurs 2006;25:256-63.
3.
Tse AC, Cheung RT, Ho SL, Chan KH. Guillain-
Barré syndrome associated with acute hepatitis E
infection. J Clin Neurosci 2012;19:607-8.
4.
Haldeman D, Zulkosky K. Treatment and nursing
care for a patient with Guillain-Barré syndrome.
Dimens Crit Care Nurs 2005;24:267-72.
5.
Khan F. Rehabilitation in Guillian Barre Syndrome.
Aust Fam Physician 2004;12:1013-7.
6.
Randomised trial of plasma exchange, intravenous
immunoglobulin, and combined treatments in
Guillain-Barré
syndrome.
Plasma
Exchange/Sandoglobulin Guillain-Barré Syndrome
Trial Group. Lancet 1997;349:225-30.
7.
Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D,
Kong K. Pilot trial of immunoglobulin versus
plasma exchange in patients with Guillain-Barré
syndrome. Neurology 1996;46:100-3.
8.
van der Meché FG, Schmitz PI. A randomized trial
comparing intravenous immune globulin and
plasma exchange in Guillain-Barré syndrome.
Dutch Guillain-Barré Study Group. N Engl J Med
1992;326:1123-9.
9.
Raphael JC, Chevret S, Harboun M, Jars-Guincestre
MC; French Guillain-Barré Syndrome Cooperative
Group. Intravenous immune globulins in patients
with
Guillain-Barré
syndrome
and